BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 1855172)

  • 1. Three-dimensional printed custom-made modular talus prosthesis in patients with talus malignant tumor resection.
    He X; Lu M; Zou C; Li Z; Gong T; Kenmegne GR; Wang Y; Luo Y; Zhou Y; Min L; Tu C
    J Orthop Surg Res; 2024 May; 19(1):273. PubMed ID: 38698477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Simple Risk Model to Predict Mortality in Patients With Osteosarcoma of the Extremity.
    Chen Y; Li C; Wang X; Liu Z; Ren Z
    Front Med (Lausanne); 2022; 9():852529. PubMed ID: 35677826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limb salvage versus amputation in patients with osteosarcoma of the extremities: an update in the modern era using the National Cancer Database.
    Evans DR; Lazarides AL; Visgauss JD; Somarelli JA; Blazer DG; Brigman BE; Eward WC
    BMC Cancer; 2020 Oct; 20(1):995. PubMed ID: 33054722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database.
    Pan Y; Chen D; Hu T; Lv G; Dai Z
    Cancer Control; 2019; 26(1):1073274819888893. PubMed ID: 31773978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of the Survival of Primary and Secondary Older Osteosarcoma Patients.
    Wang Z; Wu B; Zhou Y; Huang X; Pan W; Liu M; Yan X; Lin N; Ye Z
    J Cancer; 2019; 10(19):4614-4622. PubMed ID: 31528225
    [No Abstract]   [Full Text] [Related]  

  • 6. Osteosarcoma in patients below 25 years of age: An observational study of incidence, metastasis, treatment and outcomes.
    Nie Z; Peng H
    Oncol Lett; 2018 Nov; 16(5):6502-6514. PubMed ID: 30405789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telangiectatic osteosarcoma: a review of 87 cases.
    Angelini A; Mavrogenis AF; Trovarelli G; Ferrari S; Picci P; Ruggieri P
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2197-207. PubMed ID: 27469493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IS THERE ANY DIFFERENCE IN THE PROGNOSIS FOR PATIENTS WITH PRIMARY OSTEOSARCOMA WITH A POOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY BETWEEN HUVOS GRADES I AND II?
    Bispo Júnior RZ; Camargo OP
    Rev Bras Ortop; 2011; 46(4):420-3. PubMed ID: 27027032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience.
    Vasquez L; Tarrillo F; Oscanoa M; Maza I; Geronimo J; Paredes G; Silva JM; Sialer L
    Front Oncol; 2016; 6():22. PubMed ID: 26904501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors.
    Wadhwa N
    Indian J Orthop; 2014 May; 48(3):247-54. PubMed ID: 24932029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma.
    Kubista B; Klinglmueller F; Bilban M; Pfeiffer M; Lass R; Giurea A; Funovics PT; Toma C; Dominkus M; Kotz R; Thalhammer T; Trieb K; Zettl T; Singer CF
    Int Orthop; 2011 Mar; 35(3):401-11. PubMed ID: 20340016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy.
    Bispo Júnior RZ; Camargo OP
    Clinics (Sao Paulo); 2009; 64(12):1177-86. PubMed ID: 20037705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.
    Harting MT; Lally KP; Andrassy RJ; Vaporciyan AA; Cox CS; Hayes-Jordan A; Blakely ML
    J Cancer Res Clin Oncol; 2010 Apr; 136(4):561-70. PubMed ID: 19784847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative activity (ki-67 expression) and outcome in high grade osteosarcoma: a study of 27 cases.
    Jong R; Davis AM; Mendes MG; Wunder JS; Bell RS; Kandel R
    Sarcoma; 2000; 4(1-2):47-55. PubMed ID: 18521434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.
    Brisse H; Ollivier L; Edeline V; Pacquement H; Michon J; Glorion C; Neuenschwander S
    Pediatr Radiol; 2004 Aug; 34(8):595-605. PubMed ID: 15103428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased survival, limb preservation, and prognostic factors for osteosarcoma.
    Petrilli AS; Gentil FC; Epelman S; Lopes LF; Bianchi A; Lopes A; Figueiredo MT; Marques E; De Bellis N; Consentino E
    Cancer; 1991 Aug; 68(4):733-7. PubMed ID: 1855172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children].
    Muñoz Villa A; Ocete G; Aymerich ML; Maldonado S; Otheo E; Calvo M; Amaya J
    Med Clin (Barc); 1996 Jun; 107(5):161-4. PubMed ID: 8758673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
    Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
    Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt.
    Morsy AM; Ahmed BM; Rezk KM; Ramadan IK; Aboelgheit AM; Eltyb HA; Abd Elbadee OM; El-Naggar MS
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e66-e78. PubMed ID: 31107367
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.